For the Inventor, By the Inventor

Enter assignee name

Ibio Limited

USPTO Granted Patents = 22

CIPO Patents = 6

EPO Patents = 7

Trademarks = 6

Forward Citations = 42

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Vidadi Yusibov (15 out of 30 patents)

Vadim Mett (9 out of 22 patents)

Shailaja Rabindran (5 out of 7 patents)

4. Oleg Fedorkin (4 out of 6 patents)

5. Konstantin Musiychuk (3 out of 7 patents)

6. Matthew Paul Greving (3 out of 8 patents)

7. Mohan Srinivasan (2 out of 78 patents)

8. Jessica Chichester (2 out of 2 patents)

9. Lauren Goldschmidt (2 out of 2 patents)

10. Yoko Shoji (2 out of 2 patents)

11. Burt D Ensley (2 out of 18 patents)

12. Phung Tu Gip (2 out of 2 patents)

13. Kevin Eduard Hauser (2 out of 2 patents)

14. Angeles Estelles (1 out of 10 patents)

15. Bing Li (1 out of 12 patents)

22 patents: Sort by Forward Citations

1. 12441803 - Engineered CD25 polypeptides and uses thereof (2025-10-14),

2. 12215163 - CD25 antibodies (2025-02-04),

3. 12129302 - Anti-CD-25 antibody (2024-10-29),

4. 11673926 - In vivo de-glycosylation of recombinant proteins by co-expression with PNGase F (2023-06-13),

5. 11545238 - Machine learning method for protein modelling to design engineered peptides (2023-01-03),

6. 10844392 - Materials and methods for producing endostatin fusion polypeptides in plant cells (2020-11-24),

7. 9809644 - Influenza hemagglutinin antibodies, compositions and related methods (2017-11-07),

8. 9765349 - System for expression of genes in plants (2017-09-19),

9. 9551001 - System for expression of genes in plants (2017-01-24),

10. 9115201 - Humanized neuraminidase antibody and methods of use thereof (2015-08-25),

11. 9012199 - Recombinant carrier molecule for expression, delivery and purification of target polypeptides (2015-04-21),

12. 8962278 - Compositions and methods for production of immunoglobulins (2015-02-24),

13. 8951791 - System for expression of genes in plants (2015-02-10),

14. 8945580 - [object Object] (2015-02-03),

15. 8784819 - Influenza hemagglutinin antibodies, compositions and related methods (2014-07-22),

iBio Limited is a biotechnology company focused on developing plant-based biopharmaceuticals. Their proprietary technologies utilize plants to produce proteins and other complex molecules for therapeutic and research purposes. Through their innovative platform, iBio offers efficient and cost-effective solutions for the development and manufacturing of biologics. With a proven track record in the industry, iBio continues to advance the field of plant-based biotechnology and contribute to improved healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#1,121 in Tokyo

#2,728 in Japan

#27,908 in the World

Ibio Limited

Forward Citations = 42

44 inventors:

Vidadi Yusibov (15 out of 30 patents)

Vadim Mett (9 out of 22 patents)

Shailaja Rabindran (5 out of 7 patents)

4. Oleg Fedorkin (4 out of 6 patents)

5. Konstantin Musiychuk (3 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…